You are here: Industry Insights > BIO

News List

NGM Bio Announces Preliminary Results from NGM313 Study americanpharmaceuticalreview
November 13, 2018
NGM Bio Announces Preliminary Results from NGM313 Study
GVK BIO eyes top spot among Asian CROs biospectrumasia
October 23, 2018
With its new brand, the company will strengthen its operational expertise technology to evolve into a specialist and co
Sanofi, Translate Bio ink mRNA vaccine R&D deal worth up to $805M fiercevaccines
July 23, 2018
Moving to expand its vaccine pipeline after some slip-ups last year, Sanofi is betting on Translate Bio's mRNA platform in up to five undisclosed infectious disease targets.
Sen. Patty Murray calls out BIO, PhRMA on gender diversity efforts fiercebiotech
July 09, 2018
In the aftermath of another industry party that objectified women, Sen. Patty Murray, D-Wash., the top Democrat on the Senate Health, Education
Distek, Inc. Releases BIOne 1250 Bioprocess Control Station americanpharmaceuticalreview
June 27, 2018
From the company that has brought you over 40 years of excellence in laboratory pharmaceutical instruments, Distek, Inc. is proud to introduce the BIOne 1250 Bioprocess Control Station.
FierceBiotech BIO breakfast—CAR-T 2.0: Biomedical science at the cutting edge fiercebiotech
June 11, 2018
Every year at the BIO International Convention, FierceBiotech hosts a panel discussion about what we see as the biggest R&D talking point of the year.
BIO: Lightning round with John Maraganore fiercebiotech
June 11, 2018
BOSTON—We caught up with BIO board chair and Alnylam CEO John Maraganore at this year's meeting and asked him about a range of topics, from preserving innovation and urgency as a biotech company grows to Alnylam's pricing plan for its gene-silencing thera
Thrombolytic Science to Participate in 2018 BIO International Conference b3cnewswire.
June 04, 2018
Thrombolytic Science, LLC (TSI), a clinical stage vascular health company developing biotechnology products to treat thrombotic diseases such as myocardial infarction (MI, or heart attack) and stroke
Michigan Governor Snyder Signs Bill Facilitating Patient Access to Interchangeable Biologic Medicine biospace
March 05, 2018
The Biotechnology Innovation Organization (BIO) and MichBio commend Governor Rick Snyder for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physi
TruTag to Showcase On-Dose Authentication at BIO contractpharma
June 19, 2017
High-security solution designed to provide absolute certainty of a product’s identity

Previous page 1 2 Next page